Insider Transactions in Q2 2022 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Laurie Stelzer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,798
+50.0%
|
-
|
|
May 23
2022
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
624
-0.71%
|
$39,312
$63.54 P/Share
|